Clinical trial

EEG Analysis During Light Propofol Sedation

Name
PSS 2017/MOTANA-SCHMARTZ/MS
Description
The hypothesis of this study is that propofol sedation does not affect the detectability of a movement intention in the EEG motor cortex signal. EEG signals will be recorded during the realization of intentional movements and movement intentions by the healthy volunteers, as well as during median nerve stimulation before and during propofol perfusion according to a target control infusion. (0 µg/mL; 0.5 µg/mL and 1 µg/mL).
Trial arms
Trial start
2018-11-01
Estimated PCD
2023-10-30
Trial end
2023-12-31
Status
Recruiting
Phase
Early phase I
Treatment
Propofol
Target-controlled infusion of propofol with an effect-site concentration of 0.0 µL/mL; 0.5 µL/mL and 1.0 µL/mL.
Arms:
All subjects
Size
30
Primary endpoint
ERD/ERS amplitude
2 hours, during the experimentation
Eligibility criteria
Inclusion Criteria: * Healthy volunteers * Male * affiliated to French social security * normal physical examination * 22 \< body mass index \< 28 Exclusion Criteria: * Female * allergy to propofol or one of the emulsion compounds (soja, egg) * any pathology which may influence EEG recording or nerve conduction, such as diabetes, neuropathy, epilepsy, depression, psychotropic drug usage, drug usage) * any allergic reaction associated with anesthesia
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE1'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'interventionModelDescription': 'Every subject will have an EEG recording in the absence of propofol, or during light sedation with propofol at an effect-site target concentration of 0.5 µg/mL and 1.0 µg/mL. Each subject will be his own control.', 'primaryPurpose': 'BASIC_SCIENCE', 'maskingInfo': {'masking': 'NONE', 'maskingDescription': 'EEG will be electronically recorded and anonymised. The outcome assessor will analyse the EEG without knowledge of the propofol concentration.'}}, 'enrollmentInfo': {'count': 30, 'type': 'ESTIMATED'}}
Updated at
2023-02-16

1 organization

1 product

1 indication

Organization
Central Hospital
Product
Propofol